loading
Iterum Therapeutics Plc stock is traded at $0.732, with a volume of 496.44K. It is up +0.11% in the last 24 hours and down -24.89% over the past month. Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
See More
Previous Close:
$0.7312
Open:
$0.75
24h Volume:
496.44K
Relative Volume:
0.78
Market Cap:
$29.28M
Revenue:
-
Net Income/Loss:
$-35.58M
P/E Ratio:
-0.2762
EPS:
-2.65
Net Cash Flow:
$-42.82M
1W Performance:
-8.79%
1M Performance:
-24.89%
6M Performance:
-54.25%
1Y Performance:
-37.44%
1-Day Range:
Value
$0.72
$0.76
1-Week Range:
Value
$0.72
$0.838
52-Week Range:
Value
$0.72
$3.02

Iterum Therapeutics Plc Stock (ITRM) Company Profile

Name
Name
Iterum Therapeutics Plc
Name
Phone
(872) 225-6077
Name
Address
3 DUBLIN LANDINGS, DUBLIN 1
Name
Employee
9
Name
Twitter
Name
Next Earnings Date
2025-02-07
Name
Latest SEC Filings
Name
ITRM's Discussions on Twitter

Compare ITRM with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ITRM
Iterum Therapeutics Plc
0.732 29.25M 0 -35.58M -42.82M -2.65
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
462.13 117.32B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.87 58.89B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
401.80 51.14B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
673.80 41.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
299.01 32.59B 3.81B -644.79M -669.77M -6.24

Iterum Therapeutics Plc Stock (ITRM) Upgrades & Downgrades

Date Action Analyst Rating Change
May-28-21 Upgrade Gabelli & Co Sell → Hold
Mar-15-21 Upgrade H.C. Wainwright Neutral → Buy
Jun-02-20 Downgrade RBC Capital Mkts Outperform → Sector Perform
Jan-21-20 Downgrade Gabelli & Co Buy → Sell
Dec-11-19 Downgrade SVB Leerink Outperform → Mkt Perform
Jun-21-19 Initiated H.C. Wainwright Buy
View All

Iterum Therapeutics Plc Stock (ITRM) Latest News

pulisher
12:00 PM

Real time pattern detection on Iterum Therapeutics plc stockConsistent Gain Plan with AI Support - Newser

12:00 PM
pulisher
Aug 01, 2025

How to forecast Iterum Therapeutics plc trends using time seriesHigh Reward Investment Strategy for Beginners - Newser

Aug 01, 2025
pulisher
Aug 01, 2025

Is Iterum Therapeutics plc showing signs of accumulationWeekly Hot Stocks Based on Volume Flow - Newser

Aug 01, 2025
pulisher
Aug 01, 2025

Iterum Therapeutics plc Company Revenue and Profit Trends: A Deep DiveFree Real Profit Trade Plan Suggestions - Newser

Aug 01, 2025
pulisher
Aug 01, 2025

What moving averages say about Iterum Therapeutics plcShort Term Gain Strategy with AI Logic - Newser

Aug 01, 2025
pulisher
Aug 01, 2025

Is Iterum Therapeutics plc a growth stock or a value stockChart Pattern Growth Plan For Smart Trading - jammulinksnews.com

Aug 01, 2025
pulisher
Aug 01, 2025

Does Iterum Therapeutics plc stock perform well during market downturnsSwing Trade Alerts That Work - jammulinksnews.com

Aug 01, 2025
pulisher
Aug 01, 2025

How to use a screener to detect Iterum Therapeutics plc breakoutsPortfolio Review Summary with Five-Year Outlook - Newser

Aug 01, 2025
pulisher
Aug 01, 2025

Price momentum metrics for Iterum Therapeutics plc explainedPattern Recognition Based Market Move Prediction - Newser

Aug 01, 2025
pulisher
Aug 01, 2025

Intraday pattern recognizer results for Iterum Therapeutics plcLow Volatility Stock Analysis With Confidence - Newser

Aug 01, 2025
pulisher
Jul 31, 2025

What catalysts could drive Iterum Therapeutics plc stock higher in 2025Stock Strategy Target Finder From AI Tools - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

What are the technical indicators suggesting about Iterum Therapeutics plcRetirement Planning Insights For 2025 - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

Iterum Therapeutics to Announce Q2 2025 Earnings on Aug 5, 2025 - AInvest

Jul 31, 2025
pulisher
Jul 31, 2025

Using Ichimoku Cloud for Iterum Therapeutics plc technicalsFast Return Equity Trade Forecast Points to Small Caps - metal.it

Jul 31, 2025
pulisher
Jul 31, 2025

Why Iterum Therapeutics plc stock attracts strong analyst attentionSmart Forecast Signals from AI Models - Newser

Jul 31, 2025
pulisher
Jul 30, 2025

Iterum Therapeutics plc Price Holds Above Key Fib LevelAI Powered High Return Stock Calls Dominate Watchlists - metal.it

Jul 30, 2025
pulisher
Jul 30, 2025

Best data tools to analyze Iterum Therapeutics plc stockFree Fundamental Winners With Safe Entry Plan - Newser

Jul 30, 2025
pulisher
Jul 29, 2025

Iterum Therapeutics to Report Second Quarter 2025 Financial Results on August 5, 2025 - The Manila Times

Jul 29, 2025
pulisher
Jul 29, 2025

Antibiotics Developer Iterum Therapeutics Announces Q2 2025 Earnings Date: Key Details Inside - Stock Titan

Jul 29, 2025
pulisher
Jul 29, 2025

What makes Iterum Therapeutics plc stock price move sharplyFree Alpha Driven Watchlist With Alerts - Newser

Jul 29, 2025
pulisher
Jul 28, 2025

How strong is Iterum Therapeutics plc company’s balance sheetMarket Forecast Target Finder For 2025 - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What is the dividend policy of Iterum Therapeutics plc stockMaximize gains with data-driven stock picks - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What are analysts’ price targets for Iterum Therapeutics plc in the next 12 monthsUnmatched market performance - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Earnings Chart Overlay Points to Iterum Therapeutics plc UpsideFast Entry High Potential Stock Alerts Triggered - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

What institutional investors are buying Iterum Therapeutics plc stockUnlock daily stock market insights for success - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 25, 2025

Iterum Therapeutics plc Stock Analysis and ForecastFree Stock Market Trend Analysis - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

Is Iterum Therapeutics plc a good long term investmentSuperior risk-adjusted returns - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

What drives Iterum Therapeutics plc stock priceConsistently exceptional gains - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Iterum Therapeutics Plc (ITRM) Stock: A Year of Market Movement, Down and Up - investchronicle.com

Jul 23, 2025
pulisher
Jul 22, 2025

What analysts say about Iterum Therapeutics plc stockHigh-profit capital plays - jammulinksnews.com

Jul 22, 2025

Iterum Therapeutics Plc Stock (ITRM) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$75.59
price up icon 0.93%
$37.11
price up icon 0.84%
$108.69
price up icon 1.31%
$27.07
price up icon 2.65%
$107.34
price down icon 0.15%
biotechnology ONC
$299.01
price down icon 0.70%
Cap:     |  Volume (24h):